Intaitė B - Search Results

1

A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors.

Mlynska A, Vaišnorė R, Rafanavičius V, Jocys S, Janeiko J, Petrauskytė M, Bijeikis S, Cimmperman P, Intaitė B, Žilionytė K, Barakauskienė A, Meškauskas R, Paberalė E, Pašukonienė V. Mlynska A, et al. Among authors: intaite b. Am J Reprod Immunol. 2020 Jul;84(1):e13244. doi: 10.1111/aji.13244. Epub 2020 May 9. Am J Reprod Immunol. 2020. PMID: 32294293

2

Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization.

Mlynska A, Povilaityte E, Zemleckaite I, Zilionyte K, Strioga M, Krasko J, Dobrovolskiene N, Peng MW, Intaite B, Pasukoniene V. Mlynska A, et al. Among authors: intaite b. Am J Reprod Immunol. 2018 Sep;80(3):e12996. doi: 10.1111/aji.12996. Epub 2018 Jun 14. Am J Reprod Immunol. 2018. PMID: 29904979

3

Chemokine profiling in serum from patients with ovarian cancer reveals candidate biomarkers for recurrence and immune infiltration.

Mlynska A, Salciuniene G, Zilionyte K, Garberyte S, Strioga M, Intaite B, Barakauskiene A, Lazzari G, Dobrovolskiene N, Krasko JA, Pasukoniene V. Mlynska A, et al. Among authors: intaite b. Oncol Rep. 2019 Feb;41(2):1238-1252. doi: 10.3892/or.2018.6886. Epub 2018 Nov 27. Oncol Rep. 2019. PMID: 30483809

4

Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987-2016.

Everatt R, Intaitė B. Everatt R, et al. Among authors: intaite b. Medicina (Kaunas). 2020 Jul 13;56(7):347. doi: 10.3390/medicina56070347. Medicina (Kaunas). 2020. PMID: 32668695 Free PMC article.

5

Trends in cervical cancer mortality rates in Lithuania, 1987-2016.

Everatt R, Intaitė B. Everatt R, et al. Among authors: intaite b. Cancer Epidemiol. 2018 Dec;57:85-89. doi: 10.1016/j.canep.2018.10.008. Epub 2018 Oct 19. Cancer Epidemiol. 2018. PMID: 30347336

6

Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania.

Everatt R, Kuzmickienė I, Intaitė B, Anttila A. Everatt R, et al. Among authors: intaite b. Eur J Cancer Prev. 2020 Nov;29(6):504-510. doi: 10.1097/CEJ.0000000000000603. Eur J Cancer Prev. 2020. PMID: 32932287

7

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.

Everatt R, Kuzmickienė I, Brasiūnienė B, Vincerževskienė I, Intaitė B, Cicėnas S, Lisauskienė I. Everatt R, et al. Among authors: intaite b. BMC Cancer. 2025 Jan 8;25(1):38. doi: 10.1186/s12885-024-13273-8. BMC Cancer. 2025. PMID: 39780067 Free PMC article.

8

Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study.

Everatt R, Kuzmickienė I, Brasiūnienė B, Vincerževskienė I, Intaitė B, Cicėnas S, Lisauskienė I. Everatt R, et al. Among authors: intaite b. BMC Womens Health. 2024 Mar 4;24(1):155. doi: 10.1186/s12905-024-02983-7. BMC Womens Health. 2024. PMID: 38439058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters